Demographic and clinical features of neuromyelitis optica

A review

L. Pandit, N. Asgari, M. Apiwattanakul, J. Palace, F. Paul, M. I. Leite, I. Kleiter, T. Chitnis, Raffaele Iorio, Jens Würfel, Friedemann Paul, Daniëlle Van Pelt, Hintzen Rogier, Thomas Tedder, Albert Saiz, Pablo Villoslada, Michael Levy, Lekha Pandit, Eric Klawiter, Brian Weinshenker & 30 others Dean Wingerchuk, Ho Jin Kim, Silvia Tenembaum, Jacqueline Palace, Maria Isabel Leite, Metha Apiwattanakul, Simon Broadley, Naraporn Prayoonwiwat, Ingo Kleiter, Kerstin Hellwig, May Han, Brenda Banwell, Katja Van Herle, Anu Jacob, Craig Hooper, Douglas Kazutoshi Sato, Ichiro Nakashima, Kazuo Fujihara, Denis Bichuetti, Orhan Aktas, Jerome De Seze, Michael Yeaman, Emmanuelle Waubant, Scott Zamvil, Jeffrey Bennett, Terry Smith, Marco Lana-Peixoto, Nasrin Asgari, Benjamin Greenberg, Olaf Stuve

Research output: Contribution to journalReview article

Abstract

The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.

Original languageEnglish (US)
Pages (from-to)845-853
Number of pages9
JournalMultiple Sclerosis Journal
Volume21
Issue number7
DOIs
StatePublished - Jun 6 2015

Fingerprint

Neuromyelitis Optica
Demography
Aquaporin 4
Phenotype
Cuba
Peer Review
Far East
Incidence
Age of Onset
Population
Publications
Recurrence
Antibodies

Keywords

  • demographics
  • epidemiology
  • incidence
  • NMO
  • prevalence

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M. I., ... Stuve, O. (2015). Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis Journal, 21(7), 845-853. https://doi.org/10.1177/1352458515572406

Demographic and clinical features of neuromyelitis optica : A review. / Pandit, L.; Asgari, N.; Apiwattanakul, M.; Palace, J.; Paul, F.; Leite, M. I.; Kleiter, I.; Chitnis, T.; Iorio, Raffaele; Würfel, Jens; Paul, Friedemann; Van Pelt, Daniëlle; Rogier, Hintzen; Tedder, Thomas; Saiz, Albert; Villoslada, Pablo; Levy, Michael; Pandit, Lekha; Klawiter, Eric; Weinshenker, Brian; Wingerchuk, Dean; Kim, Ho Jin; Tenembaum, Silvia; Palace, Jacqueline; Leite, Maria Isabel; Apiwattanakul, Metha; Broadley, Simon; Prayoonwiwat, Naraporn; Kleiter, Ingo; Hellwig, Kerstin; Han, May; Banwell, Brenda; Van Herle, Katja; Jacob, Anu; Hooper, Craig; Kazutoshi Sato, Douglas; Nakashima, Ichiro; Fujihara, Kazuo; Bichuetti, Denis; Aktas, Orhan; De Seze, Jerome; Yeaman, Michael; Waubant, Emmanuelle; Zamvil, Scott; Bennett, Jeffrey; Smith, Terry; Lana-Peixoto, Marco; Asgari, Nasrin; Greenberg, Benjamin; Stuve, Olaf.

In: Multiple Sclerosis Journal, Vol. 21, No. 7, 06.06.2015, p. 845-853.

Research output: Contribution to journalReview article

Pandit, L, Asgari, N, Apiwattanakul, M, Palace, J, Paul, F, Leite, MI, Kleiter, I, Chitnis, T, Iorio, R, Würfel, J, Paul, F, Van Pelt, D, Rogier, H, Tedder, T, Saiz, A, Villoslada, P, Levy, M, Pandit, L, Klawiter, E, Weinshenker, B, Wingerchuk, D, Kim, HJ, Tenembaum, S, Palace, J, Leite, MI, Apiwattanakul, M, Broadley, S, Prayoonwiwat, N, Kleiter, I, Hellwig, K, Han, M, Banwell, B, Van Herle, K, Jacob, A, Hooper, C, Kazutoshi Sato, D, Nakashima, I, Fujihara, K, Bichuetti, D, Aktas, O, De Seze, J, Yeaman, M, Waubant, E, Zamvil, S, Bennett, J, Smith, T, Lana-Peixoto, M, Asgari, N, Greenberg, B & Stuve, O 2015, 'Demographic and clinical features of neuromyelitis optica: A review', Multiple Sclerosis Journal, vol. 21, no. 7, pp. 845-853. https://doi.org/10.1177/1352458515572406
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI et al. Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis Journal. 2015 Jun 6;21(7):845-853. https://doi.org/10.1177/1352458515572406
Pandit, L. ; Asgari, N. ; Apiwattanakul, M. ; Palace, J. ; Paul, F. ; Leite, M. I. ; Kleiter, I. ; Chitnis, T. ; Iorio, Raffaele ; Würfel, Jens ; Paul, Friedemann ; Van Pelt, Daniëlle ; Rogier, Hintzen ; Tedder, Thomas ; Saiz, Albert ; Villoslada, Pablo ; Levy, Michael ; Pandit, Lekha ; Klawiter, Eric ; Weinshenker, Brian ; Wingerchuk, Dean ; Kim, Ho Jin ; Tenembaum, Silvia ; Palace, Jacqueline ; Leite, Maria Isabel ; Apiwattanakul, Metha ; Broadley, Simon ; Prayoonwiwat, Naraporn ; Kleiter, Ingo ; Hellwig, Kerstin ; Han, May ; Banwell, Brenda ; Van Herle, Katja ; Jacob, Anu ; Hooper, Craig ; Kazutoshi Sato, Douglas ; Nakashima, Ichiro ; Fujihara, Kazuo ; Bichuetti, Denis ; Aktas, Orhan ; De Seze, Jerome ; Yeaman, Michael ; Waubant, Emmanuelle ; Zamvil, Scott ; Bennett, Jeffrey ; Smith, Terry ; Lana-Peixoto, Marco ; Asgari, Nasrin ; Greenberg, Benjamin ; Stuve, Olaf. / Demographic and clinical features of neuromyelitis optica : A review. In: Multiple Sclerosis Journal. 2015 ; Vol. 21, No. 7. pp. 845-853.
@article{fe6f44963e8c42fa9d0fb22b7723a462,
title = "Demographic and clinical features of neuromyelitis optica: A review",
abstract = "The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.",
keywords = "demographics, epidemiology, incidence, NMO, prevalence",
author = "L. Pandit and N. Asgari and M. Apiwattanakul and J. Palace and F. Paul and Leite, {M. I.} and I. Kleiter and T. Chitnis and Raffaele Iorio and Jens W{\"u}rfel and Friedemann Paul and {Van Pelt}, Dani{\"e}lle and Hintzen Rogier and Thomas Tedder and Albert Saiz and Pablo Villoslada and Michael Levy and Lekha Pandit and Eric Klawiter and Brian Weinshenker and Dean Wingerchuk and Kim, {Ho Jin} and Silvia Tenembaum and Jacqueline Palace and Leite, {Maria Isabel} and Metha Apiwattanakul and Simon Broadley and Naraporn Prayoonwiwat and Ingo Kleiter and Kerstin Hellwig and May Han and Brenda Banwell and {Van Herle}, Katja and Anu Jacob and Craig Hooper and {Kazutoshi Sato}, Douglas and Ichiro Nakashima and Kazuo Fujihara and Denis Bichuetti and Orhan Aktas and {De Seze}, Jerome and Michael Yeaman and Emmanuelle Waubant and Scott Zamvil and Jeffrey Bennett and Terry Smith and Marco Lana-Peixoto and Nasrin Asgari and Benjamin Greenberg and Olaf Stuve",
year = "2015",
month = "6",
day = "6",
doi = "10.1177/1352458515572406",
language = "English (US)",
volume = "21",
pages = "845--853",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Demographic and clinical features of neuromyelitis optica

T2 - A review

AU - Pandit, L.

AU - Asgari, N.

AU - Apiwattanakul, M.

AU - Palace, J.

AU - Paul, F.

AU - Leite, M. I.

AU - Kleiter, I.

AU - Chitnis, T.

AU - Iorio, Raffaele

AU - Würfel, Jens

AU - Paul, Friedemann

AU - Van Pelt, Daniëlle

AU - Rogier, Hintzen

AU - Tedder, Thomas

AU - Saiz, Albert

AU - Villoslada, Pablo

AU - Levy, Michael

AU - Pandit, Lekha

AU - Klawiter, Eric

AU - Weinshenker, Brian

AU - Wingerchuk, Dean

AU - Kim, Ho Jin

AU - Tenembaum, Silvia

AU - Palace, Jacqueline

AU - Leite, Maria Isabel

AU - Apiwattanakul, Metha

AU - Broadley, Simon

AU - Prayoonwiwat, Naraporn

AU - Kleiter, Ingo

AU - Hellwig, Kerstin

AU - Han, May

AU - Banwell, Brenda

AU - Van Herle, Katja

AU - Jacob, Anu

AU - Hooper, Craig

AU - Kazutoshi Sato, Douglas

AU - Nakashima, Ichiro

AU - Fujihara, Kazuo

AU - Bichuetti, Denis

AU - Aktas, Orhan

AU - De Seze, Jerome

AU - Yeaman, Michael

AU - Waubant, Emmanuelle

AU - Zamvil, Scott

AU - Bennett, Jeffrey

AU - Smith, Terry

AU - Lana-Peixoto, Marco

AU - Asgari, Nasrin

AU - Greenberg, Benjamin

AU - Stuve, Olaf

PY - 2015/6/6

Y1 - 2015/6/6

N2 - The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.

AB - The comparative clinical and demographic features of neuromyelitis optica (NMO) are not well known. In this review we analyzed peer-reviewed publications for incidence and prevalence, clinical phenotypes, and demographic features of NMO. Population-based studies from Europe, South East and Southern Asia, the Caribbean, and Cuba suggest that the incidence and prevalence of NMO ranges from 0.05-0.4 and 0.52-4.4 per 100,000, respectively. Mean age at onset (32.6-45.7) and median time to first relapse (8-12 months) was similar. Most studies reported an excess of disease in women and a relapsing course, particularly in anti-aquaporin 4 antibody (anti AQP4-IgG)-positive patients. Ethnicity may have a bearing on disease phenotype and clinical outcome. Despite limitations inherent to the review process, themes noted in clinical and demographic features of NMO among different populations promote a more global understanding of NMO and strategies to address it.

KW - demographics

KW - epidemiology

KW - incidence

KW - NMO

KW - prevalence

UR - http://www.scopus.com/inward/record.url?scp=84930410893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930410893&partnerID=8YFLogxK

U2 - 10.1177/1352458515572406

DO - 10.1177/1352458515572406

M3 - Review article

VL - 21

SP - 845

EP - 853

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 7

ER -